hemorrhage and thrombus -often with calcificationand sparse SMCs that are typically spindle-shaped rather than stellate. When atherectomy specimens from patients with post-PTCA restenosis have this appearance, the presumption has been that some primary atherosclerosis has been sampled. However, a substantial minority of atherectomy specimens from patients with primary atherosclerosis (and no PTCA) look like restenosis specimens." These may be due to recent plaque hemorrhage.
Because the histological appearances are variable, and because few samples are available for studying the events of the first hours to days after PTCA (an unrepresentative sample in any case), there is little information on the early events in human arterial injury. Studies of animals subjected to experimental atherosclerosis followed by balloon injury are important. To date, most information about the initiation of cell division and migration derives from balloon injury to the carotid artery of the rat. Because it is not yet possible to create substantial "atherosclerosis" in the rat with cholesterol feeding, most studies of balloon injury have been performed in normal rats.
Migration is Distinct from Proliferation
From 24 to 72 hours after balloon injury to the rat carotid, a subpopulation of medial SMCs (99.9% of which are not synthesizing DNA before injury) undergo DNA synthesis (Figure 1 ).9,10 These cells then migrate through breaks in the internal elastic membrane. Many of these neointimal cells continue to proliferate for several cycles and to generate an abundant and increasingly collagen-rich extracellular matrix. Nearly half of the migrating cells are not synthesizing DNA.10 Another feature that distinguishes migration from proliferation is that migration is unaffected by doses of radiation or drugs that inhibit cell division'2 and utilizes different plasminogen activators.13 Most migrating cells express urokinase plasminogen activator (u-PA) and sometimes tissue-type plasminogen activator (t-PA), and the consequent activation of plasmin and collagenases is thought to facilitate migration by digesting away obstructing thrombus and extracellular matrix proteins.14 Plasmin is also needed to lyse cell substrate attachments, releasing the cell to allow it to advance. 15 From a therapeutic standpoint, it would be useful to know the key step(s) in migration. There may be multiple pathways that are to some extent redundant, such that depriving the cells of one growth factor might make little difference if multiple alternative chemoattractants and mitogens are available.34 However, antibodies against PDGF, like antibodies against bFGF, show significant inhibition of SMCs in vivo4760 and anti-bFGF antibodies inhibit PDGF-stimulated SMC migration in vitro.88 Thus, the SMCs may respond to growth factors in an additive fashion or in sequence (such that breaking any link would sever the chain). It should also be possible to target the cell attachment factors, integrins, and related receptors required for smooth muscle migration.21
Attempts are also being made to cripple the migration machinery ("downstream" from the signal pathways) using antisense oligonucleotides to the particular isoforms of myosin and actin involved in cell migration. 89 Even further in the future is the possibility of using homologous recombination to knock out genes that are overexpressed by migrating cells. But even simpler goals like overexpressing t-PA by in vivo gene transfer are not yet practical. 90 A goal of several laboratories is the enhancement of reendothelialization. Candidates include bFGF59 and aFGF91 (which may simultaneously stimulate SMCs) as well as the endothelial-specific mitogens VEGF92 (vascular endothelial growth factor) and PD-ECGF (platelet-derived endothelial cell growth factor).93
Another theoretically attractive approach is to selectively kill the migrating SMCs by 1) 
